Using Pharmacogenetic Testing to Tailor Warfarin Therapy: The Singapore Experience and What the Future Holds
Author : Grace Shu-wen Chang, Doreen Su-Yin Tan
European Cardiology Review 2020;15:e53.
Overview:Warfarin is a widely used anticoagulant for the prevention and treatment of thromboembolic disorders. It is well known that there is considerable inter... more
Author : Rocco Antonio Montone, Giulia Iannaccone, Maria Chiara Meucci, Filippo Gurgoglione, Giampaolo Niccoli
European Cardiology Review 2020;15:e52.
Overview:In December 2019, several cases of interstitial pneumonia of unknown origin were detected in Wuhan, China, and on 9 January 2020, severe acute... more
Author : Mahmoud Abdelnabi, Nouran Eshak, Yehia Saleh, Abdallah Almaghraby
European Cardiology Review 2020;15:e51.
Overview:Pathophysiology of COVID-19-related Cardiac Injury Acute myocarditis is a potentially life-... more
Author : Michalis Kolentinis, Melanie Le, Eike Nagel, Valentina O Puntmann
European Cardiology Review 2020;15:e50.
Overview:Ischaemic heart disease (IHD) is the leading cause of morbidity and mortality worldwide. Two major pathways of disease development are acute coronary... more
Dilated Cardiomyopathy Risk in Patients with Coronavirus Disease 2019: How to Identify and Characterise it Early?
Author : Maki Komiyama, Koji Hasegawa, Akira Matsumori
European Cardiology Review 2020;15:e49.
Overview:The novel coronavirus disease (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a public health emergency... more
Ethical Issues in Decision-making Regarding the Elderly Affected by Coronavirus Disease 2019: An Expert Opinion
Author : David Martínez-Sellés, Helena Martínez-Sellés, Manuel Martinez-Sellés
European Cardiology Review 2020;15:e48.
Overview:Nearly every country is now affected by the coronavirus disease 2019 (COVID-19) pandemic. The disease is spreading rapidly and is taxing the global... more
A Multicentre, Open-Label, Randomised Controlled Clinical Trial to Assess the Efficacy and Safety of Appropriate Target Values for Lipid Management in Patients who Have Mild to Moderate Stenotic Lesions with High-Risk Plaques in Coronary Arteries: Study P
Author : Morihiro Matsuda, Koji Hasegawa
European Cardiology Review 2020;15:e47.
Overview:Aims: To investigate the efficacy of strict lipid management by secondary prevention high-risk criteria in... more
Comorbidity Differentiation and Risk Stratification in the Elderly Patient with Polypharmacy: A Prospective Primary Care Registry on Oral Anticoagulation Therapy
Author : S van Vugt, G Aarts, E Lamfers, L Bloem-de Vries, C Kramers, MJ de Boer, Freek WA Verheugt, J Jaspers Focks, M Brouwer
European Cardiology Review 2020;15:e46.
Overview:Objectives: Although polypharmacy is an accepted proxy for multi-morbidity, there has been limited attention for... more
Impacts of Adipocytokines and Obesity-associated Inflammatory Markers on Apolipoprotein A-1 and B in Patients on Statin Therapy
Author : Morihiro Matsuda
European Cardiology Review 2020;15:e45.
Overview:Background and aims: Obesity-induced chronic low-grade inflammation is causally associated with insulin resistance... more
Author : GM Sanvee, M Panajatovic, J Bouitbir, S Krähenbühl
European Cardiology Review 2020;15:e44.
Overview:Statins are lipid-lowering drugs that are beneficial for the cardiovascular system. However, they are associated with skeletal muscle disorders and, recently, with insulin... more